Remove Financial Market Remove Medicine Remove Planning
article thumbnail

2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets

Your Richest Life

Here are some of the main financial headlines so far, and what they might mean for you: Federal Reserve Holds 2025 Rates Steady At the Feds end of January meeting, they opted to keep the federal rates where they are instead of implementing another cut. Currently, the federal funds rate is at 4.25 percent to 4.50

article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. Sun Pharma’s portfolio includes innovative specialty medicines, branded generics, pure generics, and APIs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis Of Tata Chemicals – Financials, Future Plans & More

Trade Brains

After this, we’ll quickly move through the financials of the stock. A highlight of the future plans of the company and a summary conclude the article at the end. Excluding table salt, other chemicals find their end applications in the manufacturing of glass, paper products, medicines & drugs, and more. 25,395 EPS ₹90.90

article thumbnail

Sigachi Industries: Fueling Pharma Growth with High-Quality MCC

Trade Brains

We all know that the pharmaceutical industry is a complex ecosystem where countless components converge to produce life – saving medicines. MCC being a non medicinal ingredient plays a critical role in formulating tablets, capsules and other dosage forms.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. We will understand which drug market they cater to, and what opportunities lay ahead for them.

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

Following that, we’ll go into the stock’s financials. The article concludes with a highlight of future plans and a summary. Industry Overview India is the 12th-largest market in terms of value and the world’s third-largest pharmaceutical manufacturer in terms of volume. 2022 nil 26.3

article thumbnail

Fundamental Analysis Of Divis Laboratories – Profitability & More

Trade Brains

Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect. As per the company’s annual report, they have 42 process patents and plans to expand to meet the growing demand for APIs in the near future. FY 19 0.015 531.02